title: [Intensive treatment of respiratory failure--personal experiences].
abstract: Controlled oxygen-therapy was used in 30 out of 49 patients (61%) with the acute respiratory failure or exacerbations of the chronic respiratory failure treated at ICU (Group Y), while artificial ventilation in the remaining 19 patients (39%; Group B). An improvement was achieved in 70% of patients of Group A and 42% in Group B. Overall improvement was achieved in 59% of the treated patients. There were 69% of treated patients with infections. Totally 41% of the treated patients died (30% of Group A and 58% of Group B). An analysis of the results has been carried out in various subgroups of the treated patients, i.e. the acute and exacerbated respiratory failure as well as partial and complete respiratory insufficiency. The result of high risk patients have also been analysed. This subgroup included sudden cardiac arrest, shock and non-compensated acidosis. Favourable effects of the intensive care of patients with infections have been discussed with particular reference to the life hazard in case of septic complications. Emphasis is on the unfavorable effects of therapy in patients with respiratory failure complicated with pulmonary embolism. Indications to the use of respirator and complications of the artificial ventilation have been discussed.
authors.forename: S
authors.initials: S
authors.lastname: Filipecki
authors.forename: B
authors.initials: B
authors.lastname: Vertun-Baranowska
authors.forename: J
authors.initials: J
authors.lastname: Müller
authors.forename: W
authors.initials: W
authors.lastname: Pokojski
authors.forename: B
authors.initials: B
authors.lastname: Hajduk
authors.forename: A
authors.initials: A
authors.lastname: Radomyski
authors.forename: W
authors.initials: W
authors.lastname: Tomkowski
authors.forename: P
authors.initials: P
authors.lastname: Kołb
authors.forename: Z
authors.initials: Z
authors.lastname: Polowiec
mesh_terms: D001639:Bicarbonates / Q000097:blood; D002245:Carbon Dioxide / Q000097:blood; D003422:Critical Care; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010100:Oxygen / Q000097:blood; D010102:Oxygen Inhalation Therapy; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000097:blood / Q000628:therapy*
chemical_list: D001639:Bicarbonates; D002245:Carbon Dioxide; D010100:Oxygen
vernacular_title: Intensywne leczenie niewydolności oddychania--doświadczenia własne.